Electroencephalographic characterization of scopolamine-induced convulsions in fasted mice after food intake

Seizure

Volumn 15, Issue 7, 2006, Pages 509-519

  Nurten, Asiye ^a   Ozen, Ilknur ^a   Karamursel, Sacit ^a,b   Kara, Ihsan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Convulsion; EEG; Fasting; Food; Mice; Scopolamine

Indexed keywords

SCOPOLAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; ELECTRODE; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FOOD DEPRIVATION; FOOD INTAKE; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; FASTING; MALE; MICE; MICE, INBRED BALB C; MUSCARINIC ANTAGONISTS; SCOPOLAMINE; SEIZURES;

EID: 33748033696     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.06.006     Document Type: Article

References (27)

1. Enginar N., Nurten A., Yamantürk P., and Koyuncuoǧlu H. Scopolamine-induced convulsions in food given fasted mice: effects of physostigmine and MK-801. Epilepsy Res 28 (1997) 137-142
2. Enginar N., Yamantürk P., Nurten A., and Koyuncuoǧlu H. Scopolamine-induced convulsions in food given fasted mice: effects of clonidine and tizanidine. Epilepsy Res 35 (1999) 155-160
3. 3Hglutamate binding kinetics and antidopaminergic drug effects. Neuropharmacology 44 (2003) 199-205
4. Enginar N., Nurten A., Yamantürk-Çelik P., and Açi{dotless}kmeşe B. Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drug effects. Neuropharmacology 49 (2005) 293-299
5. Enginar N, Nurten A, Yamantürk P. Scopolamine-induced convulsions in fasted mice: does this effect contribute to the impairment of performance in some memory tasks? IIIrd European Research Conference on Neural Mechanisms of Learning and Memory, Abstract Book 1996; 4.2.
6. Anderson D.R., Harris L.W., Bowersox S.L., Lennox W.J., and Anders J.C. Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem Toxicol 17 (1994) 139-148
7. Turski W.A., Czuczwar S.J., Kleinrok Z., and Turski L. Cholinomimetics produce seizures and brain damage in rats. Experientia 39 (1983) 1408-1411
8. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Mello L.M., Schwarz M., and Turski L. Seizures produced by pilocarpine in mice: a behavioural electroencephalographic and morphological analysis. Brain Res 321 (1984) 237-253
9. Tan U., Şenyuva F., and Marangoz C. Electrocorticographic effects of topically applied scopolamine. Epilepsia 19 (1978) 223-232
10. Bymaster F.P., Heath I., Hendrix J.C., and Shannon H.E. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 267 (1993) 16-24
11. Dixon C.E., Ma X., and Marion D.W. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res 749 (1997) 127-130
12. Williams S., and Johnston D. Muscarinic depression of synaptic transmission at the hippocampal mossy fiber synapse. J Neurophysiol 64 (1990) 1089-1097
13. Sim J.A., and Griffith W.H. Muscarinic inhibition of glutamatergic transmissions onto rat magnocellular basal forebrain neurons in a thin-slice preparation. Eur J Neurosci 8 (1996) 880-891
14. Fisher R.S. Animal models of the epilepsies. Brain Res Rev 14 (1989) 245-278
15. Tamasi G.C., and Drenick E.J. Resistance to insulin convulsions in fasted mice. Endocrinology 92 (1973) 1277-1279
16. Steffens A.B., Scheurick A.J.N., Porte D., and Woods S.C. Penetration of peripheral glucose and insuline into cerebrospinal fluid in rats. Am J Physiol 255 (1988) R200-R204
17. Gordon N., and Newton R.W. Glucose transporter type1 (GLUT-1) deficiency. Brain Dev 27 (2003) 477-480
18. Brockman K., Korenke G.C., Moers A.V., Weise D., Klepper J., DeVivo D.C., et al. Epilepsy with seizures after fasting and retardation: The first familial cases of glucose transporter protein (GLUT-1) deficiency. Eur J Paediatr Neurol 3 (1999) A90-A91
19. Vas G.A., and Cracco J.B. Diffuse encephalopathies. In: Daly D.D., and Pedley T.A. (Eds). Current practice of clinical electroencephalography (1990), Raven Press, New York p. 371-99
20. Ito Y., Gersten E., Oguni H., Nakayama T., Matsuo M., Funatsuka M., et al. Clinical presentation, EEG studies, and novel mutations in two cases of GLUT1 deficiency syndrome in Japan. Brain Dev 27 (2005) 311-317
21. Osipova D., Ahveninen J., Kaakkola S., Jaaskelainen I.P., Huttunen J., and Pakkonen E. Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin Neurophysiol 114 (2003) 1902-1907
22. Sannita W.G., Maggi L., and Rosadini G. Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers. Neuropsychobiology 17 (1987) 199-205
23. Ebert U., Siepmann M., Oertel R., Wesnes K.A., and Kirch W. Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. J Clin Pharmacol 38 (1998) 720-726
24. Sloan E.P., Fenton G.W., and Standage K.P. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory. Biol Psychiatry 31 (1992) 600-606
25. Neufeld M.Y., Rabey M.J., Parmet Y., Sifris P., Treves T.A., and Korczyn A.D. Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patient and age-matched controls. Electroencephalogr Clin Neurophysiol 91 (1994) 407-412
26. Piercey M.F., Vogelsang G.D., Franklin S.R., and Tang A.H. Reversal of scopolamine-induced amnesia and alterations in enery metabolism by the nootropic piracetam:implications regarding identification of brain structures involved in consolidation of memory traces. Brain Res 424 (1987) 1-9
27. Remillard G.M., Zifkin B.G., and Andermann F. Seizures induced by eating. In: Zifkin B.G., Andermann F., Beaumanoir A., and Rowan A.J. (Eds). Reflex epilepsies and reflex seizures: Advances in neurology vol. 75 (1998), Lippincott-Raven Publishers, Philadelphia 227-240